JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
11 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
- Patent Trade Office reforms - H.R.1499 "Protecting Consumer Access to Generic Drugs Act of 2019", regarding all provisions - S. 1419, "Early Participation in Regulations Act of 2019", regarding all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BARNARD | — |
| DAVID KAVANAUGH | — |
Health Issues HCR
- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials - Issues related to 340B - S.4613, The Contact Lens Rule Modernization Act, regarding all provisions - H.R.3107, "Improving Seniors Timely Access to Care Act of 2019, regarding all provisions - Executive Order 13948: Lowering Drug Prices by Putting America First - Executive Order 13939: Lowering Prices for Patients by Eliminating Kickbacks to Middlemen - Executive Order 13938: Increasing Drug Importation To Lower Prices for American Patients - Executive Order 13937: Access to Affordable Life-Saving Medications -H.R.133 - Consolidated Appropriations Act, 2021, including legislation regarding average sales price (ASP) reporting requirements for certain hyaluronic acid (HA) products that are classified as devices, but reimbursed as drugs under Medicare Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| MICHAEL BARNARD | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| DEANA MCRAE New | — |
| ABIGAIL PINKELE | — |
| MEGHAN DRENAN STONE | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Environment/Superfund ENV
- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions - H.R. 2588/S. 1371 - Oxybenzone and Octinoxate Impact Study Act of 2019, regarding all provisions - H.R. 2587/S. 1375 - Reef Safe Act of 2019, regarding all provisions - Issues related to sterilization of medical devices - Issues regarding environmental sustainability
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
| MEGHAN DRENAN STONE | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Labor Issues/Antitrust/Workplace LBR
- Issues related to corporate governance - Issues related to diversity & inclusion - Issues related to racial equity and justice - Issues related to livability reform protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LARRY CAMM New | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Trade (domestic/foreign) TRD
-Issues related to new tariff proclamations and retaliation. - Issues related to mandatory supply chain requirements, including under Buy America. - H.R.6930, "MADE in America Act of 2020", regarding all provisions - 301 investigation of countries related to foreign digital service taxes and potential tariff retaliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BARNARD | — |
| LEIF BRIERLEY | — |
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to CFC look through. - Issues related to the implementation of the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 748/ S. 3458, "Coronavirus Aid, Relief, and. Economic Security Act", regarding tax provisions and future stimulus bills. - Issues related to supply chain investment incentives. - Tax issues related to Puerto Rico
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| RILEY SWINEHART | — |
Veterans VET
- Issues related to VA medical device procurement issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| RILEY SWINEHART | — |
Medicare/Medicaid MMM
- Issues related to reimbursement - HR 1425, "The Patient Protection and Affordable Care Enhancement Act", regarding all provisions - Issues related to antimicrobial resistance - Issues relating to vaccine coverage - Issues related to prior authorization in Medicare for certain medical procedures, including cervical spine fusion
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BARNARD | — |
| ABIGAIL PINKELE | — |
| RILEY SWINEHART | — |
Budget/Appropriations BUD
-Issues related to FY2020 Appropriations, specifically The Global Fund, Food & Drug Administration, Commerce, Interior, National Institutes of Health and Environmental Protection Agency budgets. -Issues related to frontline health workers -Issues related to maternal mortality and morbidity -H.R. 6800, "Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act", regarding all provisions -Issues related to contact lenses
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DARREL C JODREY | — |
| MEGHAN DRENAN STONE | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Torts TOR
- Issues related to civil justice reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| MICHAEL BARNARD | — |
| RILEY SWINEHART | — |
Science/Technology SCI
- Issues related to data privacy. - Issues related to artificial intelligence. - Issues related to cybersecurity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
| RILEY SWINEHART | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.